SCHEMBL17708369

SCHEMBL17708369

Cc1ccc(N2CCN(C3COC3)CC2)c(-n2nnn(C)c2=O)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ GAA P10253 1/20 0.36
▸ ALOX12 P18054 1/20 0.36
▸ ALK Q9UM73 4/20 0.35
▸ KIT P10721 1/20 0.35
▸ KDR P35968 1/20 0.35
▸ MAPT P10636 3/20 0.34
▸ SLC18A3 Q16572 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ PTK2 Q05397 1/20 0.33
▸ HTR7 P34969 2/20 0.33
▸ MEN1 O00255 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ POLB P06746 1/20 0.32
▸ HKDC1 Q2TB90 1/20 0.32
▸ USP2 O75604 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15322409 0.88 MAPT (0.35) SMN1; SMN2GAAALKKITKDR
SCHEMBL17708033 0.86 MAPT (0.33) SMN1; SMN2ALKKITKDRMAPT
SCHEMBL18066895 0.86 MEN1 (0.35) ALKKITKDRALDH1A1PTK2
SCHEMBL15321948 0.84 HTT (0.41) SMN1; SMN2GAAALDH1A1MEN1KMT2A
SCHEMBL19836160 0.79 ALK (0.33) ALKMAPTINSR
SCHEMBL18994945 0.77 ALK (0.34) ALKINSR
SCHEMBL17708404 0.76 HCRTR1 (0.32) MAPTSLC18A3ALDH1A1MEN1KMT2A
SCHEMBL18995035 0.75 CSF1R (0.40) ALKKITKDRPTK2INSR
SCHEMBL17665055 0.75 ALDH1A1 (0.52) SMN1; SMN2GAAALOX12MAPTSLC18A3
SCHEMBL17642603 0.73 KCNH2 (0.40) SMN1; SMN2GAAALOX12ALKKIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2833889-B1 PROTEIN KINASE C INHIBITORS AND USES THEREOF RIGEL PHARMACEUTICALS INC (US) 2017-11-01 — — EP disclosed
US-9682976-B2 Protein kinase C inhibitors and uses thereof RIGEL PHARMACEUTICALS, INC. (US) 2017-06-20 — — US disclosed
US-9321763-B2 Protein kinase C inhibitors and uses thereof RIGEL PHARMACEUTICALS, INC. (US) 2016-04-26 — — US disclosed
Send feedback